Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation - PubMed (original) (raw)
Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation
A N Murphy et al. J Cell Physiol. 1993 Nov.
Abstract
Tissue inhibitor of metalloproteinase-2 (TIMP-2), a protease inhibitor that binds to the latent and active forms of 72 kDa type IV collagenase (gelatinase A), was found to inhibit the in vitro proliferation of human microvascular endothelial (HME) cells stimulated with bFGF and 5% serum. The maximal inhibitory effect of TIMP-2 on incorporation of 3H-thymidine was evident 24 hours after bFGF stimulation of these cells and ranged between 45 and 60%. The half-maximal effective concentration of TIMP-2 was 107 +/- 12 nM (S.D.). In contrast, TIMP-1 was not found to slow the growth of HME cells. The inhibition of cell proliferation observed with TIMP-2 was not mimicked by addition to the culture medium of BB94, a general matrix metalloproteinase inhibitor, nor antibodies to the 72 kDa type IV collagenase. In addition to growth, two other cell functions associated with the angiogenic process were tested for sensitivity to TIMP-2. Cell adhesion to tissue culture plastic was slightly stimulated by TIMP-2, and cell migration was inhibited with short-term exposure to TIMP-2, but neither process was affected by longer-term exposure. The ability of TIMP-2 to inhibit cultured endothelial cell proliferation independent of protease inhibitory activity suggests that TIMP-2 may have additional actions which may limit neovascularization associated with solid tumor growth and metastasis in vivo.
Similar articles
- Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.
Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, D'Orazi G, Murphy AN, Bird RE, Hoythya M, Fuerst TR, French DL, et al. Schnaper HW, et al. J Cell Physiol. 1993 Aug;156(2):235-46. doi: 10.1002/jcp.1041560204. J Cell Physiol. 1993. PMID: 8344982 - Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.
Collen A, Hanemaaijer R, Lupu F, Quax PH, van Lent N, Grimbergen J, Peters E, Koolwijk P, van Hinsbergh VW. Collen A, et al. Blood. 2003 Mar 1;101(5):1810-7. doi: 10.1182/blood-2002-05-1593. Epub 2002 Sep 19. Blood. 2003. PMID: 12393408 - Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro.
Lamoreaux WJ, Fitzgerald ME, Reiner A, Hasty KA, Charles ST. Lamoreaux WJ, et al. Microvasc Res. 1998 Jan;55(1):29-42. doi: 10.1006/mvre.1997.2056. Microvasc Res. 1998. PMID: 9473407 - Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP. Mackay AR, et al. Invasion Metastasis. 1992;12(3-4):168-84. Invasion Metastasis. 1992. PMID: 1284126 - Matrix metalloproteinase inhibitors.
Wojtowicz-Praga SM, Dickson RB, Hawkins MJ. Wojtowicz-Praga SM, et al. Invest New Drugs. 1997;15(1):61-75. doi: 10.1023/a:1005722729132. Invest New Drugs. 1997. PMID: 9195290 Review.
Cited by
- Mechanism and its regulation of tumor-induced angiogenesis.
Gupta MK, Qin RY. Gupta MK, et al. World J Gastroenterol. 2003 Jun;9(6):1144-55. doi: 10.3748/wjg.v9.i6.1144. World J Gastroenterol. 2003. PMID: 12800214 Free PMC article. Review. - Membrane associated proteases and their inhibitors in tumour angiogenesis.
Noel A, Maillard C, Rocks N, Jost M, Chabottaux V, Sounni NE, Maquoi E, Cataldo D, Foidart JM. Noel A, et al. J Clin Pathol. 2004 Jun;57(6):577-84. doi: 10.1136/jcp.2003.014472. J Clin Pathol. 2004. PMID: 15166260 Free PMC article. Review. - Ovarian expression, localization, and function of tissue inhibitor of metalloproteinase 3 (TIMP3) during the periovulatory period of the human menstrual cycle.
Rosewell KL, Li F, Puttabyatappa M, Akin JW, Brännström M, Curry TE Jr. Rosewell KL, et al. Biol Reprod. 2013 Nov 21;89(5):121. doi: 10.1095/biolreprod.112.106989. Print 2013 Nov. Biol Reprod. 2013. PMID: 24048576 Free PMC article. Clinical Trial. - A critical role for matrix metalloproteinases in liver regeneration.
Alwayn IP, Verbesey JE, Kim S, Roy R, Arsenault DA, Greene AK, Novak K, Laforme A, Lee S, Moses MA, Puder M. Alwayn IP, et al. J Surg Res. 2008 Apr;145(2):192-8. doi: 10.1016/j.jss.2007.04.002. Epub 2008 Jan 28. J Surg Res. 2008. PMID: 18222481 Free PMC article. - Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival.
Peterson NB, Beeghly-Fadiel A, Gao YT, Long J, Cai Q, Shu XO, Zheng W. Peterson NB, et al. Int J Cancer. 2009 Aug 15;125(4):844-50. doi: 10.1002/ijc.24405. Int J Cancer. 2009. PMID: 19431211 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous